| Model: | MOS 857890-39-2 |
| Place of Origin: | Zhejiang,China (Mainland) |
| Name: | lenvatinib Mesylate |
| CAS: | 857890-39-2 |
| Molecular Formula: | C21H19ClN4O4.CH4O3S |
| Brand: | MOSINTER |
| Content: | 98%min |
| Product Categories: | API |
| Synonyms 2: | E7080 Mesylate |
- Have any questions?
- +86-189 8930 5995
- sales@mosinterchem.com.cn
lenvatinib Mesylate CAS 857890-39-2
Pazopanib CAS 444731-52-6
05/12/2018
Dasatinib Monohydrate CAS 863127-77-9
05/12/2018lenvatinib Mesylate CAS 857890-39-2 E7080 Mesylate
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment
of certain kinds of thyroid cancer, and potentially for other cancers as well.
| Usage | E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively. |
| Definition | ChEBI: A methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to r dioiodine. |
You must be logged in to post a review.
Reviews
There are no reviews yet.